Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avantor, Inc. (AVTR : NYSE)
 
 • Company Description   
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.

Number of Employees: 13,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $30.75 Daily Weekly Monthly
20 Day Moving Average: 6,054,526 shares
Shares Outstanding: 610.34 (millions)
Market Capitalization: $18,767.92 (millions)
Beta: 1.53
52 Week High: $44.37
52 Week Low: $28.64
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.52% 9.91%
12 Week -11.84% -2.80%
Year To Date -27.03% -12.59%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING ONE SUITE 200 100 MATSONFORD ROAD
-
RADNOR,PA 19087
USA
ph: 610-386-1700
fax: -
tommy.thomas@avantorsciences.com http://www.avantorsciences.com
 
 • General Corporate Information   
Officers
Michael Stubblefield - President and Chief Executive Officer
Rajiv Gupta - Chairman of the Board of Directors
Thomas A. Szlosek - Executive Vice President and Chief Financial Offic
Steven Eck - Senior Vice President and Chief Accounting Officer
Juan Andres - Director

Peer Information
Avantor, Inc. (CHCR)
Avantor, Inc. (ESRX)
Avantor, Inc. (MYDP)
Avantor, Inc. (GBCS)
Avantor, Inc. (LAXAF)
Avantor, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 05352A100
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 610.34
Most Recent Split Date: (:1)
Beta: 1.53
Market Capitalization: $18,767.92 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.38 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.51 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 31.04% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.35
Trailing 12 Months: 21.35
PEG Ratio: 0.66
Price Ratios
Price/Book: 5.60
Price/Cash Flow: 14.65
Price / Sales: 2.49
EPS Growth
vs. Year Ago Period: 8.57%
vs. Previous Quarter: 5.56%
Sales Growth
vs. Year Ago Period: 9.23%
vs. Previous Quarter: 2.24%
ROE
03/31/22 - 32.17
12/31/21 - 35.81
09/30/21 - 39.88
ROA
03/31/22 - 7.31
12/31/21 - 7.66
09/30/21 - 7.92
Current Ratio
03/31/22 - 1.80
12/31/21 - 1.71
09/30/21 - 2.70
Quick Ratio
03/31/22 - 1.18
12/31/21 - 1.11
09/30/21 - 2.06
Operating Margin
03/31/22 - 12.39
12/31/21 - 12.22
09/30/21 - 11.73
Net Margin
03/31/22 - 7.72
12/31/21 - 7.53
09/30/21 - 7.07
Pre-Tax Margin
03/31/22 - 10.38
12/31/21 - 10.19
09/30/21 - 8.80
Book Value
03/31/22 - 5.50
12/31/21 - 5.24
09/30/21 - 5.09
Inventory Turnover
03/31/22 - 5.76
12/31/21 - 5.86
09/30/21 - 6.04
Debt-to-Equity
03/31/22 - 2.03
12/31/21 - 2.19
09/30/21 - 1.79
Debt-to-Capital
03/31/22 - 61.00
12/31/21 - 62.44
09/30/21 - 57.48
 

Powered by Zacks Investment Research ©